PH26952A - Stabilization of polyprenyl compound - Google Patents

Stabilization of polyprenyl compound Download PDF

Info

Publication number
PH26952A
PH26952A PH40148A PH40148A PH26952A PH 26952 A PH26952 A PH 26952A PH 40148 A PH40148 A PH 40148A PH 40148 A PH40148 A PH 40148A PH 26952 A PH26952 A PH 26952A
Authority
PH
Philippines
Prior art keywords
tocopherol
amino acid
polyprenyl compound
group
acid
Prior art date
Application number
PH40148A
Other languages
English (en)
Inventor
Keizo Uesugi
Nobutaka Noda
Michiru Tanaka
Masanori Kayano
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1065384A external-priority patent/JP2928261B2/ja
Priority claimed from JP6538589A external-priority patent/JP2812977B2/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH26952A publication Critical patent/PH26952A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pyrane Compounds (AREA)
PH40148A 1989-03-17 1990-03-07 Stabilization of polyprenyl compound PH26952A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1065384A JP2928261B2 (ja) 1989-03-17 1989-03-17 安定なポリプレニル系化合物含有組成物の製法
JP6538589A JP2812977B2 (ja) 1989-03-17 1989-03-17 ポリプレニル系化合物含有硬カプセル剤の製造方法

Publications (1)

Publication Number Publication Date
PH26952A true PH26952A (en) 1992-12-03

Family

ID=26406534

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40148A PH26952A (en) 1989-03-17 1990-03-07 Stabilization of polyprenyl compound

Country Status (10)

Country Link
US (1) US5304381A (de)
EP (1) EP0387655B1 (de)
KR (1) KR920005812B1 (de)
AT (1) ATE100709T1 (de)
DE (1) DE69006236T2 (de)
DK (1) DK0387655T3 (de)
ES (1) ES2062133T3 (de)
FI (1) FI901046A7 (de)
NO (1) NO178137C (de)
PH (1) PH26952A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW523816B (en) 2000-06-16 2003-03-11 Gen Semiconductor Inc Semiconductor trench device with enhanced gate oxide integrity structure
US12083226B2 (en) * 2018-07-30 2024-09-10 Daiichi Sankyo Company, Limited Stabilizer-containing solid drug formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH433944A (de) * 1962-12-17 1967-04-15 Hoffmann La Roche Präparat zur Vitaminierung von Lebens- und Futtermitteln und Verfahren zu dessen Herstellung
JPS5115094B2 (de) * 1972-11-01 1976-05-14
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
JPS5832873A (ja) * 1981-08-20 1983-02-25 Eisai Co Ltd ポリプレニルアミド系化合物含有組成物
DE3201511A1 (de) * 1982-01-20 1983-07-28 Henkel Kgaa Sebosuppressive kosmetische mittel, welche laengerkettige alkanole und antioxidantien enthalten
EP0138216B1 (de) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited IFN-Präparat mit verzögerter Abgabe für parentale Verabreichung
US4711894A (en) * 1986-01-16 1987-12-08 Henkel Corporation Stabilized tocopherol in dry, particulate, free-flowing form
FI96169C (fi) * 1989-07-10 1996-05-27 Eisai Co Ltd Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi

Also Published As

Publication number Publication date
DE69006236T2 (de) 1994-07-07
NO178137B (no) 1995-10-23
FI901046A0 (fi) 1990-03-01
KR920005812B1 (ko) 1992-07-20
ES2062133T3 (es) 1994-12-16
NO178137C (no) 1996-01-31
DK0387655T3 (da) 1994-02-28
US5304381A (en) 1994-04-19
ATE100709T1 (de) 1994-02-15
EP0387655B1 (de) 1994-01-26
KR900013957A (ko) 1990-10-22
EP0387655A3 (de) 1991-06-05
FI901046A7 (fi) 1990-09-18
DE69006236D1 (de) 1994-03-10
EP0387655A2 (de) 1990-09-19
NO901209L (no) 1990-09-18
NO901209D0 (no) 1990-03-15

Similar Documents

Publication Publication Date Title
FI89005B (fi) Foerfarande foer framstaellning av en doseringsform av etodolac med foerdroejd utloesning
US6306434B1 (en) Pharmaceutical composition comprising cyclosporin solid-state microemulsion
FI104408B (fi) Menetelmä kaksifaasisten vapautusformulaatioiden valmistamiseksi lipofiilisiä lääkkeitä varten
CA2804635C (en) Formulations of rifaximin and uses thereof
US6605298B1 (en) Pharmaceutical compositions and their use
EP1940366A1 (de) Weichkapseln mit palonosetron-hydrochlorid mit verbesserter stabilität und bioverfügbarkeit
CN1162265A (zh) 口服施用的具有简单组成和高生物利用度的环孢菌素新制剂形式及其制造方法
MX2009000145A (es) Capsulas duras llenas con liquido que contiene ibuprofeno.
WO1995001166A1 (en) Encapsulated medicine
SK37298A3 (en) Cyclosporin-containing soft capsule preparations
HU220870B1 (en) Pharmaceutical compositions for oral administration containing rapamycin and process for the preparation thereof
PH26952A (en) Stabilization of polyprenyl compound
CN110382006B (zh) 吸收促进剂及其应用
CA2011985A1 (en) Stabilization of polyprenyl compound
KR20010013588A (ko) 세르트랄린의 젤라틴 캡슐화된 용액 투여형
JP2812977B2 (ja) ポリプレニル系化合物含有硬カプセル剤の製造方法
US20050220866A1 (en) Novel capsule formulations of etoposide for oral use
EP0625898B1 (de) Liposomale piroxycam formulierung
WO2026015623A2 (en) Pharmaceutical formulations comprising dydrogesterone and methods of preparation thereof
KR20050019198A (ko) 가용성 덱시부프로펜의 연질캅셀제 조성물 및 그의 제조방법
KR100592687B1 (ko) 암로디핀을 함유하는 연질캡슐제 조성물 및 그 제조방법
EP0775488A1 (de) Stabile pharmazeutische Zubereitung auf Basis von Acetylsalicylsäure und Tocopherol
KR0170525B1 (ko) 로얄젤리와 히드로코르티손을 유효성분으로 하는 피부질환 치료용 외용크림제 조성물
KR20050028409A (ko) 자가 미세 유화형 약물 전달 시스템을 이용하는 소염 진통활성을 갖는 약제 조성물
WO2005032516A1 (en) Formulation and manufacturing process of self-microemulsified aceclofenac soft capsules